Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 376.90 INR
Change Today +1.20 / 0.32%
Volume 6.6K
JBP On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:28 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

jenburkt pharmaceuticals (JBP) Snapshot

Open
372.00
Previous Close
375.70
Day High
391.50
Day Low
368.00
52 Week High
04/15/15 - 465.00
52 Week Low
05/30/14 - 101.70
Market Cap
1.8B
Average Volume 10 Days
10.1K
EPS TTM
20.75
Shares Outstanding
4.6M
EX-Date
--
P/E TM
18.2x
Dividend
6.30
Dividend Yield
1.35%
Current Stock Chart for JENBURKT PHARMACEUTICALS (JBP)

Related News

No related news articles were found.

jenburkt pharmaceuticals (JBP) Related Businessweek News

No Related Businessweek News Found

jenburkt pharmaceuticals (JBP) Details

Jenburkt Pharmaceuticals Ltd. manufactures and markets pharmaceutical formulations and healthcare products in India and internationally. It primarily offers prescription medicines across various therapeutic areas, such as anti-arthritic, antimalarials, anti-osteoporotic, antibiotics, antidiabetics, anti-inflammatory drugs, gastro intestinal, dermatological, aphrodisiac, anti-ulcerant drugs, anti-hypertensive, anthelmintics, hematinics, neuropathy, and protein preparation, as well as over-the-counter drugs. The company was founded in 1985 and is based in Mumbai, India.

Founded in 1985

jenburkt pharmaceuticals (JBP) Top Compensated Officers

Chairman, Managing Director, Member of Stakeh...
Total Annual Compensation: 7.8M
Chief Financial Officer, Whole Time Director,...
Total Annual Compensation: 1.3M
Compensation as of Fiscal Year 2014.

jenburkt pharmaceuticals (JBP) Key Developments

Jenburkt Pharmaceuticals Ltd Announces Audited Standalone Financial Results for the Fourth Quarter and Year Ended March 31, 2015

Jenburkt Pharmaceuticals Ltd. announced audited standalone financial results for the fourth quarter and year ended March 31, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 222.455 million against INR 199.320 million a year ago. Total income from operations (net) was INR 223.581 million against INR 199.350 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 32.488 million against INR 23.300 million a year ago. Profit from ordinary activities before tax was INR 47.665 million against INR 30.823 million a year ago. Net profit from ordinary activities after tax was INR 22.380 million or INR 4.81 per basic and diluted share before and after extraordinary items against INR 23.098 million or INR 4.97 per basic and diluted share before and after extraordinary items a year ago. For the year, the company reported net sales/income from operations (net of excise duty) of INR 850.180 million against INR 762.000 million a year ago. Total income from operations (net) was INR 852.104 million against INR 762.245 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 125.942 million against INR 99.637 million a year ago. Profit from ordinary activities before tax was INR 143.399 million against INR 103.103 million a year ago. Net profit from ordinary activities after tax was INR 96.491 million or INR 20.75 per basic and diluted share before and after extraordinary items against INR 75.063 million or INR 16.15 per basic and diluted share before and after extraordinary items a year ago.

Jenburkt Pharmaceuticals Ltd Announces Resignation of Devangi S. Shah as Independent Director

Jenburkt Pharmaceuticals Ltd. announced that the Board of Directors of the company at its meeting held on May 21, 2015, accepted the resignation of Ms. Devangi S. Shah as Independent Director.

Jenburkt Pharmaceuticals Ltd. Recommends Dividend

Jenburkt Pharmaceuticals Ltd. announced that the Board of Directors of the company at its meeting held on May 21, 2015, the board has approved dividend of INR 6.30 (63%) per equity share of INR 10 each.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JBP:IN 376.90 INR +1.20

JBP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JBP.
View Industry Companies
 

Industry Analysis

JBP

Industry Average

Valuation JBP Industry Range
Price/Earnings 17.8x
Price/Sales 2.0x
Price/Book 5.2x
Price/Cash Flow 14.0x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JENBURKT PHARMACEUTICALS, please visit www.jenburkt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.